Literature DB >> 23139243

Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.

Juan M Fernandez-Costa1, Amparo Garcia-Lopez, Sheila Zuñiga, Victoria Fernandez-Pedrosa, Amelia Felipo-Benavent, Manuel Mata, Oihane Jaka, Ana Aiastui, Francisco Hernandez-Torres, Begoña Aguado, Manuel Perez-Alonso, Jesus J Vilchez, Adolfo Lopez de Munain, Ruben D Artero.   

Abstract

Myotonic dystrophy type 1 (DM1) is caused by the expansion of CTG repeats in the 3' untranslated region of the DMPK gene. Several missplicing events and transcriptional alterations have been described in DM1 patients. A large number of these defects have been reproduced in animal models expressing CTG repeats alone. Recent studies have also reported miRNA dysregulation in DM1 patients. In this work, a Drosophila model was used to investigate miRNA transcriptome alterations in the muscle, specifically triggered by CTG expansions. Twenty miRNAs were differentially expressed in CTG-expressing flies. Of these, 19 were down-regulated, whereas 1 was up-regulated. This trend was confirmed for those miRNAs conserved between Drosophila and humans (miR-1, miR-7 and miR-10) in muscle biopsies from DM1 patients. Consistently, at least seven target transcripts of these miRNAs were up-regulated in DM1 skeletal muscles. The mechanisms involved in dysregulation of miR-7 included a reduction of its primary precursor both in CTG-expressing flies and in DM1 patients. Additionally, a regulatory role for Muscleblind (Mbl) was also suggested for miR-1 and miR-7, as these miRNAs were down-regulated in flies where Mbl had been silenced. Finally, the physiological relevance of miRNA dysregulation was demonstrated for miR-10, since over-expression of this miRNA in Drosophila extended the lifespan of CTG-expressing flies. Taken together, our results contribute to our understanding of the origin and the role of miRNA alterations in DM1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139243     DOI: 10.1093/hmg/dds478

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

1.  Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.

Authors:  Chiara Fritegotto; Chiara Ferrati; Valentina Pegoraro; Corrado Angelini
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

2.  The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.

Authors:  Auinash Kalsotra; Ravi K Singh; Priyatansh Gurha; Amanda J Ward; Chad J Creighton; Thomas A Cooper
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

3.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

Review 4.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

Review 5.  RNA-protein interactions in unstable microsatellite diseases.

Authors:  Apoorva Mohan; Marianne Goodwin; Maurice S Swanson
Journal:  Brain Res       Date:  2014-04-04       Impact factor: 3.252

6.  Transcriptome alterations in myotonic dystrophy skeletal muscle and heart.

Authors:  Eric T Wang; Daniel Treacy; Katy Eichinger; Adam Struck; Joseph Estabrook; Hailey Olafson; Thomas T Wang; Kirti Bhatt; Tony Westbrook; Sam Sedehizadeh; Amanda Ward; John Day; David Brook; J Andrew Berglund; Thomas Cooper; David Housman; Charles Thornton; Christopher Burge
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 7.  The role of microRNAs in skeletal muscle health and disease.

Authors:  Tyler J Kirby; Thomas Chaillou; John J McCarthy
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

8.  Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model.

Authors:  Ariadna Bargiela; Estefanía Cerro-Herreros; Juan M Fernandez-Costa; Juan J Vilchez; Beatriz Llamusi; Ruben Artero
Journal:  Dis Model Mech       Date:  2015-07-01       Impact factor: 5.758

Review 9.  Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies.

Authors:  Edyta Koscianska; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.

Authors:  Andrie Koutsoulidou; Tassos C Kyriakides; George K Papadimas; Yiolanda Christou; Evangelia Kararizou; Eleni Zamba Papanicolaou; Leonidas A Phylactou
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.